Jörg H. W. Distler
← Back to Heinrich Heine University Düsseldorf
Heinrich Heine University Düsseldorf
Jörg H. W. Distler works in Systemic Sclerosis and Related Diseases, Dupuytren's Contracture and Treatments, Pulmonary Hypertension Research and Treatments, Connective tissue disorders research, TGF-β signaling in diseases. Recorded institutional associations include Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Düsseldorf University Hospital.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
2016 · 5,856 citationsPlasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 · 5,035 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
2021 · 2,608 citationsUpdate of EULAR recommendations for the treatment of systemic sclerosis
2016 · 1,107 citationsActivation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 · 838 citationsMapping and predicting mortality from systemic sclerosis
2017 · 691 citationsShared and distinct mechanisms of fibrosis
2019 · 637 citationsMicroRNA‐29, a key regulator of collagen expression in systemic sclerosis
2010 · 539 citationsEffects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
2014 · 434 citationsAngiogenic and angiostatic factors in the molecular control of angiogenesis.
2003 · 398 citationsImatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
2006 · 384 citationsActivation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
2017 · 355 citationsOrphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
2015 · 342 citationsThe induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles
2005 · 328 citationsEvidence of innate lymphoid cell redundancy in humans
2016 · 320 citationsUncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis
2004 · 312 citationsThe identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
2020 · 310 citationsPotential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
2019 · 296 citationsResolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells
2017 · 282 citationsThe Potential of Adiponectin in Driving Arthritis
2006 · 278 citationsTargeting TGF-β signaling for the treatment of fibrosis
2018 · 274 citationsAutophagy regulates TNFα-mediated joint destruction in experimental arthritis
2012 · 269 citationsIncidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
2016 · 268 citationsPlatelet-derived serotonin links vascular disease and tissue fibrosis
2011 · 267 citationsOverview of pathogenesis of systemic sclerosis
2006 · 242 citations
